Global Anti-Inflammatory Drugs Market Forecast To Reach $228.83 Billion By 2029 With 10.8% Annual Growth
The Business Research Company
The Business Research Company's Anti-Inflammatory Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- The anti-inflammatory drugs market size has grown rapidly in recent years. From $136.86 billion in 2024, it is predicted to reach $152.08 billion in 2025 at a compound annual growth rate CAGR of 11.1%. Factors attributing to this growth include an aging population, rising prevalence of chronic inflammatory diseases, increased over-the-counter availability, growing awareness of pain management, and expansion of healthcare infrastructure.
What Is The Anti-Inflammatory Drugs Market Growth Forecast?
Excitingly, the anti-inflammatory drugs market is anticipated to see even greater growth in the coming years, rising up to $228.83 billion in 2029 at a CAGR of 10.8%. This increase in the forecast period can be put down to the rising incidence of autoimmune diseases, a growing demand for personalized medicine, an expanding geriatric population, supportive government initiatives, and rising preference for topical and targeted therapies.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=24465&type=smp
What's Driving Anti-Inflammatory Drugs Market Growth Specifically?
A key factor driving the growth of the anti-inflammatory drugs market is the rising prevalence of arthritis. This condition, an inflammation of one or more joints causing pain, swelling, and stiffness, typically worsens with age. As people grow older and joints experience more wear and tear, the likelihood of developing arthritis increases. Anti-inflammatory drugs are beneficial in managing arthritis because they reduce joint inflammation and pain, helping patients maintain better mobility and perform daily activities with greater ease, ultimately improving their overall quality of life.
Who Are The Key Industry Players?
Prominent companies operating in the anti-inflammatory drugs market include Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, and Lupin Limited.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report
What Emerging Trends Can We Witness?
Major companies in the market are focusing efforts on developing innovative formulations such as topical solutions to enhance targeted delivery and improve patient compliance. For instance, Lupin Limited, an India-based pharmaceutical company, launched the authorized generic version of PENNSAID Diclofenac Sodium Topical Solution, 2% w/w of Horizon Pharma Therapeutics in the United States in December 2022. This development was rolled out to extend its U.S. generics portfolio and increase accessibility to affordable anti-inflammatory treatments.
How Is The Anti-Inflammatory Drugs Market Segmented?
The anti-inflammatory drugs market covered in this report is segmented into the following categories:
1 By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs NSAIDs, Biologics And Biosimilars, Other Drug Classes
2 By Route of Administration: Parenteral, Oral, Topical, Inhalation
3 By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4 By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Moreover, it is also divided into subsegments:
1 By Steroids: Corticosteroids, Mineralocorticoids
2 By Nonsteroidal Anti-Inflammatory Drugs NSAIDs: Non-Selective Nonsteroidal Anti-Inflammatory Drugs NSAIDs, Selective Cyclooxygenase-2 COX-2 Inhibitors
3 By Biologics And Biosimilars: Tumor Necrosis Factor TNF Inhibitors, Interleukin IL Inhibitors, Janus Kinase JAK Inhibitors, Other Biologics And Biosimilars
4 By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs DMARDs, Immunosuppressants, Antihistamines.
Any Anti-Inflammatory Drugs Market Regional Insights?
In 2024, North America was the largest region in the anti-inflammatory drugs market. However, Asia-Pacific is pegged as the fastest-growing region in the forecast period.
Browse Through More Similar Reports By The Business Research Company:
Rheumatology Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
Rare Inflammatory Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report
About The Business Research Company
The Business Research Company, with over 15,000 reports from 27 industries covering 60+ geographies, has built a reputation for offering comprehensive, data-rich research and insights. With 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+ +44 7882 955267
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Geothermal Rising Welcomes Geothermal Incentives in Big Beautiful Bill, Honors Geothermal Community’s Dedication
RESTIV Appoints Proven Industry Leader as New Director of Sales and Customer Satisfaction
Last Captive Elephant in Argentina Begins Her Historic Journey to Elephant Sanctuary Brazil
Więcej ważnych informacji
![37,5 proc. środków z Planu Społeczno-Klimatycznego trafi na walkę z ubóstwem transportowym. Organizacje branżowe apelują o zmianę priorytetowych projektów [DEPESZA]](https://www.newseria.pl/files/1097841585/rower3,w_85,_small.jpg)
Jedynka Newserii
Jedynka Newserii
Bankowość
Rośnie liczba i wartość udzielonych konsumentom kredytów gotówkowych. Gorzej mają się kredyty ratalne oraz te udzielane firmom
Rynek kredytowy w Polsce co do zasady rośnie, choć nierównomiernie. Z danych Biura Informacji Kredytowej wynika, że najlepiej rozwija się segment kredytów gotówkowych dla konsumentów. Wartościowo wzrosła też kwota udzielonych limitów w kartach kredytowych. Według prognoz BIK w całym roku wzrośnie wartość zarówno udzielonych kredytów mieszkaniowych, jak i gotówkowych, choć tych pierwszych poniżej inflacji. Wcześniejsze cięcia stóp procentowych przez RPP nie zmieniły tej prognozy.
Transport
37,5 proc. środków z Planu Społeczno-Klimatycznego trafi na walkę z ubóstwem transportowym. Organizacje branżowe apelują o zmianę priorytetowych projektów [DEPESZA]
Ministerstwo Funduszy i Polityki Regionalnej z końcem czerwca zakończyło konsultacje Planu Społeczno-Klimatycznego, który otwiera drogę do pozyskania 65 mld zł (11,4 mld euro) z unijnego Społecznego Funduszu Klimatycznego. Polska będzie jego największym beneficjentem, a 37,5 proc. budżetu zostanie przeznaczone na bezpośrednie wsparcie osób narażonych na ubóstwo transportowe. Organizacje branżowe oceniają jednak, że walka z tym zjawiskiem może się okazać nieskuteczna. W toku konsultacji zgłosiły swoje zastrzeżenia co do priorytetów w wydatkach i sposobu wsparcia inwestycji w transport rowerowy.
Prawo
Firmy będą mogły przetestować krótszy tydzień pracy z rządowym wsparciem. Nabór wniosków ruszy w sierpniu
Ministerstwo Rodziny, Pracy i Polityki Społecznej uruchamia pilotaż krótszego tygodnia pracy. Zainteresowane wzięciem w nim udziału firmy będą się mogły ubiegać o wsparcie finansowe ze strony rządu. Politycy Nowej Lewicy, którzy są pomysłodawcami testu tego rozwiązania, przekonują, że finalnie zyskają na nim wszyscy, zarówno pracownicy, jak i pracodawcy, a ostrzeżenia o spodziewanych problemach gospodarki są mocno przesadzone.
Partner serwisu
.gif)
Szkolenia
Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.
|
|
|